Author:
Kurosaka Shinji,Satoh Takefumi,Chow Edward,Asano Yuji,Tabata Ken-ichi,Kimura Masaki,Tsumura Hideyasu,Matsumoto Kazumasa,Ishiyama Hiromichi,Inoue Yusuke,Hayakawa Kazushige,Baba Shiro
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference17 articles.
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
2. Henkin RE, Del Rowe JD, Grigsby PW, Hartford AC, Jadvar H, Macklis RM, et al. ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical Sources. Clin Nucl Med. 2011;36(8):e72–80.
3. Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Petrilli G, et al. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med. 2002;43(1):79–86.
4. Bolger JJ, Dearnaley DP, Kirk D, Lewington VJ, Mason MD, Quilty PM, et al. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group. Semin Oncol. 1993;20(3 Suppl 2):32–3.
5. Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer. 2009;45(7):1146–52.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献